Citation Formats
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. C. Kluin-Nelemans Et Al. , "Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis," THERANOSTICS , vol.11, no.1, pp.292-303, 2021

Kluin-Nelemans, H. C. Et Al. 2021. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. THERANOSTICS , vol.11, no.1 , 292-303.

Kluin-Nelemans, H. C., Jawhar, M., Reiter, A., van Anrooij, B., Gotlib, J., Hartmann, K., ... Illerhaus, A.(2021). Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. THERANOSTICS , vol.11, no.1, 292-303.

Kluin-Nelemans, Hanneke Et Al. "Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis," THERANOSTICS , vol.11, no.1, 292-303, 2021

Kluin-Nelemans, Hanneke C. Et Al. "Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis." THERANOSTICS , vol.11, no.1, pp.292-303, 2021

Kluin-Nelemans, H. C. Et Al. (2021) . "Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis." THERANOSTICS , vol.11, no.1, pp.292-303.

@article{article, author={Hanneke C. Kluin-Nelemans Et Al. }, title={Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis}, journal={THERANOSTICS}, year=2021, pages={292-303} }